E. Gharib

Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients: BIOFLOW V Acute Coronary Syndromes Subgroup

J. Massaro, A. Roguin, D. Kandzari, 2018, Circulation. Cardiovascular Interventions.

Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial

J. Massaro, L. Mauri, A. Roguin, 2017, The Lancet.

Impact of Race and Ethnicity on the Clinical and Angiographic Characteristics, Social Determinants of Health, and 1-Year Outcomes After Everolimus-Eluting Coronary Stent Procedures in Women: Insights From the Pooled PLATINUM Diversity and PROMUS ELEMENT PLUS Postapproval Studies

R. Mehran, D. Kandzari, J. Chandrasekhar, 2019, Circulation. Cardiovascular interventions.